Interestingly, vaccination by combination of TRP-2-encoding mRNA and siRNA was found to more prominently delay tumor growth compared to co-administration of a TRP-2 mRNA vaccine and an anti-PD-1 (programmed cell death protein 1) monoclonal antibody. The gene discussed is PDCD1; the disease is neoplasm.